24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Drug Offers Hope Against Tough-to-Treat Chronic CoughWeight Gain Is No Friend to Aging LungsSugary Sodas Wreak Havoc With Cholesterol Levels, Harming the HeartMore Countries Report Coronavirus Cases, as Outbreak in U.S. Looks CertainU.S. Veterans With Blocked Leg Arteries Seeing Better ResultsBad Sleep, Bad Diet = Bad Heart?Could Heartburn Meds Spur Growth of Drug-Resistant Germs in Your Gut?How Coronavirus Raced Through Quarantined Cruise ShipCoronavirus Outbreak in America Is Coming: CDCGlobal Coronavirus Outbreaks Raise Fears of PandemicGlobal Coronavirus Outbreaks Worry Experts, as U.S. Cases Reach 34Sticking With Meds Lowers Lupus Patients' Diabetes RiskU.S. Coronavirus Cases Reach 34: CDCAHA News: Research Opens New Avenues to Reduce Foot, Toe AmputationsYour Best Bet Against Heart Attack, Stroke? Lower Blood PressureLung Diseases on the Rise WorldwideNew China Coronavirus Cases Decline, 2 Passengers From Affected Cruise Ship DieAHA News: What Women Need to Know About Breast Cancer and Heart DiseaseU.S. Scientists Take Key Step Towards Towards Coronavirus VaccineQuarantine Ends on Cruise Ship in Japan as Coronavirus Cases Near 75,000AHA News: Race and Gender May Tip the Scales on Traditional Stroke Risk FactorsMeasles Complications Can Affect Every Organ: StudyBabies' Exposure to Household Cleaning Products Tied to Later Asthma RiskCoronavirus: Are U.S. Hospitals Prepared?14 Americans From Cruise Ship Hit By Coronavirus Test Positive for InfectionHot Chocolate Could Help Ease Painful Clogged Leg VesselsAntiviral Drug, Plasma Transfusions Show Promise in Treating CoronavirusHow to Dispel Your Child's Fears About the New CoronavirusCholesterol Drugs Might Help Curb 'High-Risk' Prostate CancersCoronavirus Spreads Most Easily When Patients Are Sickest: CDCWill Brushing and Flossing Protect You Against Stroke?Young Black Adults More Prone to Stroke, but Don't Know ItAHA News: Stroke Rates Down for Mexican Americans, Up for White AdultsCoronavirus Cases, Deaths Rise Sharply, While 2 New Cases Reported in U.S.Scientists Spot Antibody That Might Help Diagnose, Treat Autoimmune DisordersCoronavirus in America: Keep Your Panic in CheckCoronavirus Spread Slows, But Death Toll Jumps to 1,113Growing Up in U.S. 'Stroke Belt' Bad for the Brain Later in LifeShingles Vaccine Bonus: Reduced Risk of Stroke?Air Pollution Made in One State Can Cause Deaths in OthersWere You Born in an H1N1 Flu Year or an H3N2? It MattersStricter Clean Air Laws Could Save Thousands of Lives a Year: StudyCoronavirus Fears Have U.S. Pharmacies Running Out of Face MasksCoronavirus Death Toll Tops 1,000, While 13th U.S. Case ConfirmedMeds May Not Prevent Migraines in KidsHigh Testosterone Levels Have Different Health Impact for Men and WomenCoronavirus Cases Top 40,000, While Deaths Hit 908With Macular Degeneration, 1 Missed Visit to Eye Doc Can Mean Vision LossHundreds Suspected, 12 Confirmed: How CDC Identified U.S. Coronavirus CasesFor Patients on Blood Thinners, GI Bleeding May Signal Colon Cancer: Study
Questions and AnswersLinks
Related Topics

Diabetes

Heart Transplants From Donors With Hepatitis C May Be Safe: Study

HealthDay News
by -- Robert Preidt
Updated: Jan 13th 2020

new article illustration

MONDAY, Jan. 13, 2020 (HealthDay News) -- One-year survival rates are similar for transplant patients who receive a heart from a donor with hepatitis C or one without the infectious virus, a new study finds.

The researchers suggest that using hearts from donors with hepatitis C, a viral infection of the liver, may be safe and could help reduce a U.S. organ shortage.

The study included nearly 7,900 adults with heart failure who received heart transplants at 128 U.S. medical centers. Just over 4% received hearts from donors with hepatitis C.

A year after their transplant, 90% of patients whose donors had hepatitis C and 91% of patients whose donors were not infected were still alive, the findings showed.

The two groups also had similar rates of drug-treated organ rejection, stroke and kidney dialysis to remove toxins from the blood, according to findings published Jan. 8 in the Journal of the American Heart Association.

"We are encouraged by these results and believe this is a landmark change in our ability to better meet the demand for heart transplantation by increasing the donor supply," lead author Dr. Arman Kilic said in a journal news release. Kilic is co-director of the Center for Cardiovascular Outcomes and Innovation at the University of Pittsburgh Medical Center.

"It is our hope that more centers will use hepatitis C-positive donors for heart transplantation," Kilic added.

More than 6 million people in the United States have heart failure and more than 900,000 new cases are diagnosed every year, according to the American Heart Association.

While lifestyle changes and medications can help manage mild cases, patients with severe heart failure may need a transplant.

The researchers noted several limitations to their study, including a lack of information about the type of hepatitis C infection donors had, past treatment and whether organ recipients later developed hepatitis C.

The study also was limited to one-year survival and included only a small number of patients with hearts from donors with hepatitis C.

More information

The U.S. National Heart, Lung, and Blood Institute has more on heart transplant.